ACT

Insider trade Sale by Genworth Holdings, Inc.

20h ago

News Enact Holdings raises quarterly dividend by 14% to $0.24/share

27d ago

SEC filing ACT Reports $168M Net Income, $1.18 EPS, 12.5% ROE, $272B IIF, 2% YoY Growth, 162% PMIERs Sufficiency

27d ago

Insider trade Sale by Genworth Holdings, Inc.

31d ago

Insider trade Sale by James Mcmullen (Controller)

83d ago

Insider trade Sale by Michael Derstine (EVP and Chief Risk Officer)

89d ago

Insider trade Sale by Genworth Holdings, Inc.

91d ago

Insider trade Sale by Robert P Restrepo JR

104d ago

Insider trade Sale by Genworth Holdings, Inc.

104d ago

News CVS Caremark Replaces Amgen And Eli Lilly's Branded Drugs, Expands Biosimilar Strategy For Weak Bone Disorder

115d ago

News Enact Announces New $500 Million Share Repurchase Program and $0.21 Per Share Quarterly Dividend

118d ago

News Enact Holdings Non-GAAP EPS of $1.23 beats by $0.13, revenue of $312.71M misses by $4.31M

118d ago

News Nebius Group (NBIS) Carries Strong Potential for Margin Expansion and Free Cash Flows

125d ago

Scanner Unusual volume (z=4.3)

160d ago

Scanner Unusual volume (z=4.3)

162d ago

Scanner Unusual volume (z=4.3)

163d ago

Scanner Unusual volume (z=4.3)

164d ago